Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Stock Screener
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
More
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
Log in
English
中文繁體
中文简体
Download
Mobile
moomoo Desktop
The next-gen workspace
Download now
Click to view more download content
Sign up/Log in
English
Light
Dark
Back
Investments
Options
Stocks
ETFs
Fractional Shares
Cash Sweep
Features
Paper Trade
Charts
Stock Analysis
Level 2 Data
Moomoo Desktop
Market Analysis
Real-time Quotes
Stocks Market
Options Market
Futures Market
ETF Market
Forex Market
Technical Tools
Heat Map
Earnings Calendar
Institutional Tracker
Trading News
Headlines
Latest News
Financial Calendar
Trending Topics
Video Analysis
Pricing
Pricing
Margin Rate
Promotions
Welcome Bonus
Moomoo Monday
Moomoo Million
Referral Promotion
Transfer Bonus
Resources
Strategies and Insights
Blogs
Moomoo Guide
Moomoo Tutorials
Moomoo Lessons
Investment Courses
Moomoo Community
Feed
Discussions
Featured Content
Support
About Us
About moomoo
Moomoo Highlights
Moomoo Foundation
Influencer Program
Investor Relations
You will leave moomoo.com and for FUTU holdings Ltd. website.
English
中文繁體
中文简体
Dark
Light
Open Account
Download
Log in to access Online Inquiry
Back to the Top
Watchlist
Paper Trade
Screener
Heat Map
Institutional
Tracker
CN Stock Market
Detailed Quotes
301096 Hangzhou Bio-Sincerity Pharma-Tech
Watchlist
34.98
+0.61
+1.77%
Market Closed May 9 15:00 CST
3.82B
Market Cap
-29.67
P/E (TTM)
35.47
High
34.17
Low
32.34Klot
Volume
34.42
Open
34.37
Pre Close
112.76M
Turnover
4.66%
Turnover Ratio
Loss
P/E (Static)
109.23M
Shares
69.40
52wk High
1.50
P/B
2.43B
Float Cap
30.60
52wk Low
41.24
Limit Up
69.43M
Shs Float
118.30
Historical High
27.50
Limit Down
3.78%
Amplitude
30.60
Historical Low
0.30
Dividend TTM
34.86
Avg Price
14.44Klot
Ask
0.86%
Div YieldTTM
100
Lot Size
16.62Klot
Bid
Overview
Financials
Analysis
Company
News
Comments
Hangzhou Bio-Sincerity Pharma-Tech Stock Forum
Sign in
to post a comment
No comment yet
- No more -
Sign in
to post a comment
Market Insights
Top Gaining Chinese Stocks
Top Gaining Chinese Stocks
No.
Symbol
% Chg
Hangzhou Wensli Silk Culture
301066
+20.03%
Yoantion Industrial Inc.,
301053
+19.99%
Xinlei Compressor
301317
+19.82%
4
QIFENG
873169
+17.45%
5
LAISAI LASER
871263
+17.14%
Log In for the Full List
Unlock Now
Market Headlines
Pony.ai Shares Surge 35%+ on Uber Robotaxi Joint Venture in Middle East
May 7 00:22
May's Must-See Financial Events: Apple & Nvidia Earnings, Berkshire Meeting, Interest Rate Decision, and More
Apr 30 16:04
PDD Attracts Second Biggest Option Block Trade, Behind Apple: Options Chatter
Apr 30 02:20
Pony AI Shares Rally 60%+ Intraday After Cost Cutting Brings Profitability Closer
Apr 29 02:17
BYD Doubles Quarterly Profit as Chinese Automaker Outpaces Tesla
Apr 25 22:10
Latest News
06:52
Brazil's Solicitor General Says Case Related to the Payment of Undue Benefits to Agricultural Inspectors
06:50
Brazil's Minerva Agrees to Pay 22 Million Reais to Settle Dispute With Brazilian Authorities - Statement From Solicitor General
06:38
Texas AttorNey GenErAl Ken PaxTon Secures $1.375 BilLion SetTleMent With Google RelatEd to TexAns’ Data PriVaCy Rights- Statement
GOOGL
-0.99%
Hangzhou Bio-Sincerity Pharma-Tech Stock Forum
No comment yet